Sign in Subscribe
Class action lawsuits

Cytokinetics Securities Lawsuit: Potential Recovery for Damaged Investors

Strategic Insights

— 1 min read

A class action lawsuit has been filed against Cytokinetics, Incorporated, alleging securities fraud in relation to the company's NDA submission and approval process for aficamten. The lawsuit claims that defendants made materially false and misleading statements about the regulatory timeline, failing to disclose material risks related to the Company's failure to submit a Risk Evaluation and Mitigation Strategy (REMS). This deception led to significant losses for investors who purchased Cytokinetics' common stock at artificially inflated prices. The law firm Levi & Korsinsky is representing aggrieved shareholders and offering a free consultation to those who suffered losses.

Key Takeaways:

  • The class action lawsuit was filed against Cytokinetics, Incorporated, alleging securities fraud between December 27, 2023 and May 6, 2025.
  • Defendants made allegedly false and misleading statements regarding the NDA submission and approval process for aficamten, including the expected PDUFA date of September 26, 2025.
  • The complaint claims that Cytokinetics failed to disclose material risks related to the Company's failure to submit a Risk Evaluation and Mitigation Strategy (REMS) that could delay the regulatory process.
  • LEVI & KORSINSKY, the law firm representing the aggrieved shareholders, has a proven track record of securing hundreds of millions of dollars for investors in complex securities litigation.
  • The firm has extensive expertise and a team of over 70 employees, ranking as one of the top securities litigation firms in the United States for seven consecutive years.

Statistics:

  • The lawsuit covers the period between December 27, 2023 and May 6, 2025.
  • The alleged securities fraud resulted in significant losses for investors who purchased Cytokinetics' common stock at artificially inflated prices.
  • Cytokinetics expected approval from the FDA for NDA submission in the second half of 2025.
  • The Law firm Levi & Korsinsky has secured hundreds of millions of dollars for investors in complex securities litigation over the past 20 years.

Sources:

  • https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=168276&wire=5
  • https://www.newsfilecorp.com/release/267078

Read more